What is Glipizide?
Category: Prescription Drugs
Most popular types: Glipizide ER Glipizide XL Glucotrol Show all
Glipizide is an anti-diabetic medicine (sulfonylurea-type) used along with a proper diet and exercise program to control high blood sugar. It is used in patients with type 2 diabetes (non-insulin-dependent diabetes). It works by stimulating the release of the body's natural insulin.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Diabetes type 2 | 3965 | 144 | |
| Elevated blood sugar (hyperglycemia) | 11 | 3 | |
| Maturity-onset diabetes in young | 7 | 0 | |
| Blood sugar swings | 1 | 0 | |
| Blurry vision | 1 | 15 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 9 | |
| Moderate | 2 | |
| Mild | 18 | |
| None | 118 |
Commonly reported side effects and conditions associated with Glipizide
| Side effect | Patients | Percentage |
|---|---|---|
| Low blood sugar (hypoglycemia) | 9 | |
| Diarrhea | 2 | |
| Stomach pain | 2 | |
| Tiredness | 2 | |
| Weight gain | 2 | |
| Constant tiredness | 1 |
Why patients stopped taking Glipizide
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Doctor's advice | 42 | |
| Did not seem to work | 23 | |
| Side effects too severe | 16 | |
| Other | 7 | |
| Course of treatment ended | 5 | |
| Change in health plan coverage | 2 | |
| Expense | 1 |
Duration
Stopped taking Glipizide
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 18 | |
| 1 - 6 months | 7 | |
| 6 months - 1 year | 6 | |
| 1 - 2 years | 4 | |
| 2 - 5 years | 13 | |
| 5 - 10 years | 16 | |
| 10 years or more | 4 |
What people switch to and from
Patients started taking Glipizide after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Metformin (Metformin ER) | 29 | |
| Glyburide (Euglukon) | 5 | |
| Glimepiride (Amaryl) | 3 | |
| Insulin Glargine (Lantus) | 2 | |
| Exenatide (Bydureon) | 1 |
Patients stopped taking Glipizide and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Metformin (Metformin ER) | 16 | |
| Insulin Glargine (Lantus) | 9 | |
| Sitagliptin (Januvia) | 5 | |
| Insulin NPH-insulin regular (Novolin Mix 70/30) | 4 | |
| Dulaglutide (Trulicity) | 2 |
Last updated: